Resultado de búsqueda
Fosun International Limited is a Chinese multinational conglomerate holding company. [4] Founded in 1992 by Guo Guangchang and four others, the company is headquartered in Shanghai and was incorporated in Hong Kong in 2004. Its Co-CEOs are Chen Qiyu and Xu Xiaoliang.
- Fosun Pharma
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (trade name:...
- Fosun Pharma
See main article Fosun International Since 1994, Guo has been the chairman of Fosun Group and invested in insurance, pharmaceuticals and healthcare, property, steel, mining, retail, services, finance and other investment, and asset management, creating one of the largest non-state owned enterprises in China. [6]
- 3
- Wang Jinyuan
- Businessman
- Fudan University
In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2023, Fosun International’s total assets amounted to RMB808.4 billion; it received an AA MSCI ESG rating and was the only conglomerate in Greater China with such rating. 808.4. RMB808.4 billion Total assets
Fosun International (復星國際有限公司, 复星国际有限公司) ( SEHK: 656) est le plus grand conglomérat privé de Chine continentale 3, 4. Son siège social est à Shanghai. Le groupe est divisé en trois grands domaines d'activités : santé (nutrition, environnement, recherche et développement en pharmacie ...
The globalization journey of Fosun started in 2007 when Fosun International was listed in Hong Kong. After nearly 16 years, Fosun has established businesses in more than 35 countries and regions (based enterprises with revenue exceeding RMB 100 million in such year).
Fosun International is an innovation-driven consumer group providing high-quality products and services for families around the world in health, happiness and wealth businesses, with total assets of RMB715.7 billion (c. $102.6 billion) as of 31 December 2019 and total revenue of RMB143.0 billion (c. $20.7 billion) in 2019, and ranks No.371 on th...
